ERASURE:早期自体血胸膜固定术治疗术后漏气——一项比较预防性自体血胸膜固定术与标准观察等待治疗胸腔镜解剖性肺切除术后漏气的随机对照试验
该随机对照试验纳入因原发性肺癌或转移性疾病行择期胸腔镜解剖性肺切除、术后第二天晨查前6小时内漏气>100 ml/min的患者,随机分入自体血胸膜固定术组或观察等待组。主要终点为以全天数计算的拔管时间,试验于术后第七天结束。目的为探讨预防性自体血胸膜固定术能否缩短术后漏气持续时间并防止其转为迁延性漏气。
要点
- 择期胸腔镜解剖性肺切除、术后第二天晨查前6小时内漏气>100 ml/min者纳入随机分组。
- 主要终点为以全天数计算的拔管时间,试验于术后第七天结束。
- 干预为预防性自体血胸膜固定术,对照为观察等待。
核心结论
- 早期自体血胸膜固定术可能使漏气更快停止,从而更快拔除引流管,并可能减轻引流管相关并发症、降低住院及门诊带管护理费用。
研究设计与样本
- 随机对照试验,纳入因原发性肺癌或转移性疾病行择期胸腔镜解剖性肺切除、术后第二天晨查前6小时内漏气>100 ml/min的患者,随机分入自体血胸膜固定术组或观察等待组,主要终点为以全天数计算的拔管时间,试验于术后第七天结束。
主要发现
- 约10-20%接受肺切除的患者最终发生迁延性漏气。
- 术后胸腔镜肺叶切除术住院时间可短至2天。
- 预防性自体血胸膜固定术可能使漏气更快停止并更快拔除引流管。
关键数值与推荐
- 纳入随机分组条件:术后第二天晨查前6小时内漏气>100 ml/min。
- 主要终点:以全天数计算的拔管时间。
- 试验结束时间:术后第七天。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prolonged air leak is probably the most common complication following lung resections. Around 10-20% of the patients who undergo a lung resection will eventually develop a prolonged air leak. The definition of a prolonged air leak varies between an air leak, which is evident after the fifth, seventh or even tenth postoperative day to every air leak that prolongs the hospital stay. However, the postoperative hospital stay following a thoracoscopic lobectomy can be as short as 2 days, making the above definitions sound outdated. The treatment of these air leaks is also very versatile. One of the broadly accepted treatment options is the autologous blood pleurodesis or "blood patch". The purpose of this trial is to investigate the impact of a prophylactic autologous blood pleurodesis on reducing the duration of the postoperative air leak and therefore prevent the air leak from becoming prolonged. METHODS: Patients undergoing an elective thoracoscopic anatomic lung resection for primary lung cancer or metastatic disease will be eligible for recruitment. Patients with an air leak of > 100 ml/min within 6 h prior to the morning round on the second postoperative day will be eligible for inclusion in the study and randomization. Patients will be randomized to either blood pleurodesis or watchful waiting. The primary endpoint is the time to drain removal measured in full days. The trial ends on the seventh postoperative day. DISCUSSION: The early autologous blood pleurodesis could lead to a faster cessation of the air leak and therefore to a faster removal of the drain. A faster removal of the drain would relieve the patient from all the well-known drain-associated complications (longer hospital stay, stronger postoperative pain, risk of drain-associated infection, etc.). From the economical point of view, faster drain removal would reduce the hospital costs as well as the costs associated with the care of a patient with a chest drain in an outpatient setting. TRIAL REGISTRATION: German Clinical Trials Register (DRKS) DRKS00030810. 27 December 2022.
引用
- Karampinis I, Ruckes C, Doerr F, et al. ERASURE: early autologous blood pleurodesis for postoperative air leaks-a randomized, controlled trial comparing prophylactic autologous blood pleurodesis versus standard watch and wait treatment for postoperative air leaks following thoracoscopic anatomic lung resections. Trials. 2024. PMID: 38166982. doi:10.1186/s13063-023-07875-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。